Insights into the Metabolism, Disposition, and Quantitative Profile of mGlu5 NAM AE90015 with Metabolite Identification and a Novel Integration Method
Zhiyang Zack Zou, Ming-Jie Han, Yu Chang, Guiying Li, Irene Panderi · 2024
Read Insights into the Metabolism, Disposition, and Quantitative Profile of mGlu5 NAM AE90015 with Metabolite Identification and a Novel Integration Method by Zhiyang Zack Zou, Ming-Jie Han, Yu Chang, Guiying Li, Irene Panderi (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11643612.txt.
Description
Zhiyang Zou and colleagues trace what happens to a drug candidate called AE90015 inside the body. The compound blocks the mGlu5 receptor and shows promise for Parkinson's disease. Knowing how a drug breaks down and leaves the body is a basic step before human trials.
Rats got the drug by mouth, and the team sampled urine, bile, blood, and organs over a day. They found thirty breakdown products, sorted into four families, using high-resolution mass tools. Simple oxidation did almost all the clearing work. Bile, not urine, carried away most of the waste, an upset of the usual assumption. The paper also debuts a method that merges light and mass signals to measure overlapping peaks.
Catalog record
| CREATOR | Zhiyang Zack Zou, Ming-Jie Han, Yu Chang, Guiying Li, Irene Panderi |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |